In our study, HNRNPA2B1 was positively correlated with activated CD4+ memory T cells and activated myeloid dendritic cells, implying that HNRNPA2B1 may enhance the efficacy of immunotherapy through regulating the tumor-infiltrating immune cells. The gene discussed is HNRNPA2B1; the disease is neoplasm.